SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH H impact

Mega Lifesciences' 4Q 2026 to 2027 Earnings Growth Likely to Be Healthy — Market Talk

Mega Lifesciences' earnings growth in 4Q 2026 to 2027 is likely to be healthy, Maybank Securities (Thailand)'s Wasu Mattanapotchanart says in a research report. The healthcare company's revenue should grow 3% from the preceding quarter in 4Q, supported by the high season for branded product sales…

MEGA

Related stories